2022's Top Rx Pharma Brands by TV Ad Spend

Rinvoq, an AbbVie JAK inhibitor immunology drug, was the No. 1 prescription pharmaceutical brand when it came to estimated national TV ad spend in 2022, according to iSpot.tv data shared with FiercePharma. It spent about $315.8 million on TV ads during the year, a noticeable increase from its $165 million estimated TV ad spend in 2021.

Some additional insights around TV ads from the top pharma brands in 2022:

• In total, the top ten brands spent about $1.68 billion, a slight increase from 2021's $1.61 billion.
• Dupixent, a Sanofi and Regeneron immunology drug, was No. 2 for estimated TV ad spend with $305.9. In 2021, the brand was the No. 1 spender for Rx pharma with $287.6 million.
• Verzenio was the only brand that made the top ten for spend in 2022 but not in 2021; it took tenth place for 2022 spend with $111.8 million, up from $70.1 million in 2021 (No. 18).